These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 3274303)

  • 1. Influence of cyclosporine on in situ cellular and humoral immune responses during allograft rejection.
    Orosz CG; Sirinek LP; Zinn NE; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1175-7. PubMed ID: 3274303
    [No Abstract]   [Full Text] [Related]  

  • 2. The immunobiology of experimental lung transplantation with cyclosporine immunosuppression: cytolytic T lymphocytes and delayed type hypersensitivity in rejecting and tolerant recipients.
    Norin AJ
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):125-30. PubMed ID: 2966476
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective immunosuppression by drugs in balanced immune responses.
    Heppner GH; Griswold DE; Di Lorenzo J; Poplin EA; Calabresi P
    Fed Proc; 1974 Aug; 33(8):1882-5. PubMed ID: 4602113
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of immunosuppression on rejection of cartilage formed by transplanted allogeneic rib chondrocytes in mice.
    Malejczyk J; Osiecka A; Hyc A; Moskalewski S
    Clin Orthop Relat Res; 1991 Aug; (269):266-73. PubMed ID: 1864049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel saves rat heart allografts from rejection by inhibition of the primed anti-donor humoral and cellular immune response: implications for transplant patients with cancer.
    Tange S; Scherer MN; Graeb C; Andrassy J; Justl M; Frank E; Jauch KW; Geissler EK
    Transpl Int; 2003 Jul; 16(7):471-5. PubMed ID: 12677363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of niridazole in cellular immunity in vivo and in vitro.
    Solbach W; Wagner H; Röllinghoff M
    Clin Exp Immunol; 1978 Jun; 32(3):411-8. PubMed ID: 357051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concanavalin A-dependent cell-mediated cytotoxicity in bronchoalveolar lavage fluid. Correlation with lung allograft rejection in mongrel dogs during cyclosporine dose tapering.
    Norin AJ; Kamholz SL; Pinsker KL; Emeson EE; Veith FJ
    Transplantation; 1986 Nov; 42(5):466-72. PubMed ID: 3538531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of cyclophosphamide on the rejection of allogenic rat kidney transplants. An in vitro study of cell-bound and antibody-mediated immunity.
    Husberg BS
    Clin Exp Immunol; 1972 Apr; 10(4):697-711. PubMed ID: 4556105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cytotoxic T lymphocytes in corneal allograft rejection.
    Hegde S; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3341-7. PubMed ID: 11006223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine and organ transplantation.
    Steinmuller DR
    Cleve Clin Q; 1985; 52(2):263-70. PubMed ID: 3161666
    [No Abstract]   [Full Text] [Related]  

  • 11. Action of theophylline on humoral and cellular immune response mechanisms.
    Gillissen G
    Allergol Immunopathol (Madr); 1981; Suppl 9():218-22. PubMed ID: 7349730
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune mechanisms in organ allograft rejection. III. Cellular and humoral immunity in rejection of organ allografts transplanted across MHC subregion disparity RT1.B (RT1.D).
    Lowry RP; Gurley KE
    Transplantation; 1983 Oct; 36(4):405-11. PubMed ID: 6353708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ and systemic cellular immunity associated with orthotopic rat liver allograft acceptance or rejection.
    Ruiz P; Harland R; Yamaguchi Y; Bollinger RR; Sanfilippo F
    Transplant Proc; 1989 Feb; 21(1 Pt 1):416-20. PubMed ID: 2650164
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of the donor-specific immune response by cyclosporin-A following renal transplantation.
    Keown PA; Stiller CR; Ulan RA; Sinclair NR; Rankin C; Carruthers G; Wall WJ
    Transplant Proc; 1981 Sep; 13(3):1669-72. PubMed ID: 6458135
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunostimulation by Alsophila spinulosa extract fraction VII of both humoral and cellular immune responses.
    Kao SF; Kuo HL; Lee YC; Chiang HC; Lin YS
    Anticancer Res; 1994; 14(6B):2439-43. PubMed ID: 7872664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of graft rejection by LPS: further evidence for effects on T lymphocytes.
    Winchurch RA; Hilberg C; Birmingham W; Munster AM
    J Reticuloendothel Soc; 1982 Jan; 31(1):31-42. PubMed ID: 6977643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of cell-mediated immunity in the mouse following administration of 4-nitroquinoline 1-oxide.
    Outzen HC; Prehn RT
    Cancer Res; 1973 Feb; 33(2):408-10. PubMed ID: 4569790
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunomodulating effects of anticancer drugs: the example of adriamycin.
    Mihich E; Ehrke MJ
    Transplant Proc; 1984 Apr; 16(2):499-501. PubMed ID: 6609456
    [No Abstract]   [Full Text] [Related]  

  • 19. Failure of bleomycin to affect humoral or cell-mediated immunity in the mouse.
    Dlugi AM; Robie KM; Mitchell MS
    Cancer Res; 1974 Oct; 34(10):2504-7. PubMed ID: 4137660
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of ICRF 159 on immune responses.
    Hellmann K
    Proc R Soc Med; 1972 Mar; 65(3):264-5. PubMed ID: 4563302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.